EcoDrugPlus

Tubulin Alpha 4a

Ensembl ID : ENSPKIG00000017497
Gene Symbol: TUBA4A
4 Cross references
133 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPKIG00000002008
Gene Symbol: TUBA4A
4 Cross references
129 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSPKIG00000004818
Gene Symbol: LOC111854703
2 Cross references
67 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSPKIG00000008719
Gene Symbol: TUBB2B
2 Cross references
90 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPKIG00000019889
Gene Symbol: TUBB3
2 Cross references
140 Possible Orthologues:

Tubulin Beta-5 Chain

Ensembl ID : ENSPKIG00000010354
Gene Symbol: LOC111837874
3 Cross references
141 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSPKIG00000003668
Gene Symbol: TUBB1
1 Cross references
182 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPKIG00000001744
Gene Symbol: TP53
4 Cross references
160 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPKIG00000002320
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosinase-Like

Ensembl ID : ENSPKIG00000023265
Gene Symbol: LOC111833935
3 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPKIG00000001023
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPKIG00000015788
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).